124
Participants
Start Date
December 18, 2008
Primary Completion Date
September 28, 2011
Study Completion Date
September 28, 2011
Placebo
Placebo for subcutaneous injection
NPSP558
Parathyroid hormone 50, 75, or 100 mcg injectable subcutaneously daily
Columbia University Medical Center, New York
University Physicians Group, Staten Island
Children's Hospital of Philadelphia, Philadelphia
Physicians East, Greenville
Mayo Clinic Jacksonville, Jacksonville
Palm Springs Research Institute, Hialeah
University of Cincinnati Bone Health and Osteoporosis Center, Cincinnati
Indiana University School of Medicine, Indianapolis
Michigan Bone and Mineral Clinic PC, Detroit
Mayo Clinic Rochester, Rochester
University of Chicago Medical Center, Chicago
Hillcrest Family Health Center, Waco
Cetero Research DGD Research Inc., San Antonio
Mayo Clinic-Scottsdale, Scottsdale
Advance Medical Research LLC, Lakewood
Diabetes Associates, Orange
University of California-San Francisco VA Medical Center, San Francisco
The Vancouver Clinic, Vancouver
Massachusetts General Hospital, Boston
Chetre Hospitalier Universitaire de Liege, Liège
Heritage Medical Research Clinic, Calgary
Capital District Health Authority, QEII Health Sciences Centre, Halifax
Oakville Bone Center, Oakville
Aarhus University Hospital, Aarhus
Odense University Hospital, Odense
Hôpital Européen Georges Pompidou, Paris
Semmelweis University Medical School, Budapest
University of Pécs, School of Medicine, Pécs
University of Szeged, Szeged
University Hospital of Careggi, Florence
Royal Liverpool University Hospital, Liverpool
Lead Sponsor
Shire
INDUSTRY